CU24095B1 - ANTICUERPO MONOCLONAL AISLADO PARA PROTEÍNAS PBP2a - Google Patents
ANTICUERPO MONOCLONAL AISLADO PARA PROTEÍNAS PBP2aInfo
- Publication number
- CU24095B1 CU24095B1 CU2012000026A CU20120026A CU24095B1 CU 24095 B1 CU24095 B1 CU 24095B1 CU 2012000026 A CU2012000026 A CU 2012000026A CU 20120026 A CU20120026 A CU 20120026A CU 24095 B1 CU24095 B1 CU 24095B1
- Authority
- CU
- Cuba
- Prior art keywords
- pbp2a
- proteins
- monoclonal antibody
- isolated monoclonal
- pbp2a proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Gram-positive bacteria
- C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invención se refiere a anticuerpos monoclonales capaces de reconocer y unirse a proteínas PBP2a y PBP5 y otras proteínas que presentan secuencias homólogas a PBP2a, incluyendo los patógenos Staphylococcus aureus resistentes a meticilina-MRSA y Enterococcus faecalis.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0914508-7A BRPI0914508B1 (pt) | 2009-08-10 | 2009-08-10 | ANTICORPOS MONOCLONAIS PARA A PROTEÍNA PBP2a, E, COMPOSIÇÃO FARMACÊUTICA |
| PCT/BR2010/000263 WO2011017791A1 (pt) | 2009-08-10 | 2010-08-10 | Anticorpos monoclonais para a proteína pbp2-a e sequências homólogas para o tratamento de infeçcões e imunodiagnóstico em bactérias do filo firmicutes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CU20120026A7 CU20120026A7 (es) | 2012-06-21 |
| CU24095B1 true CU24095B1 (es) | 2015-04-29 |
Family
ID=45896895
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20140101A CU24180B1 (es) | 2009-08-10 | 2010-08-10 | Anticuerpo monoclonal aislado para proteina pbp5 |
| CU2012000026A CU24095B1 (es) | 2009-08-10 | 2010-08-10 | ANTICUERPO MONOCLONAL AISLADO PARA PROTEÍNAS PBP2a |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20140101A CU24180B1 (es) | 2009-08-10 | 2010-08-10 | Anticuerpo monoclonal aislado para proteina pbp5 |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JP5785544B2 (es) |
| CN (1) | CN102741281B (es) |
| AU (1) | AU2010282162B2 (es) |
| CA (1) | CA2770771C (es) |
| CU (2) | CU24180B1 (es) |
| SG (1) | SG178346A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3415160B1 (en) * | 2014-03-04 | 2021-08-18 | Klinikum der Universität München | Polypeptides derived from enterococcus and their use for vaccination and the generation of therapeutic antibodies |
| CN105315367B (zh) * | 2014-07-29 | 2019-01-29 | 广州瑞博奥生物科技有限公司 | 用于检测耐甲氧西林金黄色葡萄球菌的酶联免疫试剂盒 |
| BR102020016890A2 (pt) * | 2020-08-19 | 2022-05-03 | Fundação Oswaldo Cruz | Proteina, polinucleotídeo, vetor, célula hospedeira, composição, método para tratar uma doença, método in vitro para prognosticar esclerose múltipla, e, uso de uma proteína ou composição |
| CN113150139B (zh) * | 2021-02-01 | 2022-09-09 | 深圳市龙华区疾病预防控制中心 | 一种PBP2a单克隆抗体及其制备方法和应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003503015A (ja) * | 1999-05-03 | 2003-01-28 | メダレツクス・インコーポレーテツド | スタフィロコッカス・アウレウスに対するヒト抗体 |
-
2010
- 2010-08-10 CU CU20140101A patent/CU24180B1/es active IP Right Grant
- 2010-08-10 SG SG2012009205A patent/SG178346A1/en unknown
- 2010-08-10 AU AU2010282162A patent/AU2010282162B2/en active Active
- 2010-08-10 JP JP2012524064A patent/JP5785544B2/ja active Active
- 2010-08-10 CU CU2012000026A patent/CU24095B1/es active IP Right Grant
- 2010-08-10 CN CN201080043628.XA patent/CN102741281B/zh active Active
- 2010-08-10 CA CA2770771A patent/CA2770771C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2770771A1 (en) | 2011-02-17 |
| RU2012108941A (ru) | 2013-09-20 |
| CN102741281B (zh) | 2015-02-25 |
| AU2010282162B2 (en) | 2016-06-02 |
| CU20140101A7 (es) | 2015-01-29 |
| SG178346A1 (en) | 2012-03-29 |
| CU24180B1 (es) | 2016-04-25 |
| JP2013501732A (ja) | 2013-01-17 |
| AU2010282162A8 (en) | 2012-05-24 |
| CN102741281A (zh) | 2012-10-17 |
| AU2010282162A1 (en) | 2012-04-05 |
| CA2770771C (en) | 2019-12-03 |
| JP5785544B2 (ja) | 2015-09-30 |
| CU20120026A7 (es) | 2012-06-21 |
| HK1176077A1 (en) | 2013-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122278T1 (el) | Αντι il-36r αντισωματα | |
| CY1123518T1 (el) | Ανθρωπινα αντισωματα enanti-tau | |
| MX2020001879A (es) | Proteínas de fijación al antígeno que se dirigen a antígenos compartidos. | |
| BR112013020500A8 (pt) | anticorpo isolado, recombinante ou purificado | |
| ECSP18023386A (es) | Moléculas de unión a linfopoyetina estromal timica (tslp) y métodos de uso de las moléculas | |
| MX2025002735A (es) | Virus oncolitico que codifica un inhibidor de la molecula 4 asociada a linfocitos t citotoxicos (ctla-4) y su uso en el tratamiento de cancer | |
| MX373426B (es) | Moleculas de enlace a il-18. | |
| CO2018002446A2 (es) | Moléculas de unión a linfopoyetina estromal timica (tslp) y métodos de uso de las moléculas | |
| CY1120471T1 (el) | Αντισωματα κατα του cd70 | |
| CY1122978T1 (el) | Αντισωματα εναντι-vla-4 | |
| CR20130016A (es) | ANTICUERPOS PEPTIDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS | |
| SG159458A1 (en) | Novel immunoglobulin-binding proteins with improved specificity | |
| CY1121673T1 (el) | Εξουδετερωση αντισωματων στις κυριες εξωτοξινες tcda και tcdb της λοιμωξης clostridium difficile | |
| PL3181581T3 (pl) | Przeciwciała o zmodyfikowanym powinowactwie do FcRn, które wspomagają klierens antygenu | |
| CY1115639T1 (el) | Διειδικα αγωνιστικα αντισωματα υποδοχεα θανατου | |
| CR20110400A (es) | Proteinas de enlace al receptor cgrp humano | |
| BR112018071276A2 (pt) | anticorpos anti-il-33, composições, métodos e usos dos mesmos | |
| DK2352763T4 (da) | Bispecifikke enkeltkædede antistoffer med specificitet for højmolekylære målantigener | |
| CO6440515A2 (es) | Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento c3b | |
| CR20120210A (es) | Proteínas de enlace al antigeno il-23 humanas | |
| UY35168A (es) | Composiciones y métodos de anticuerpos de marcaje de epo | |
| CR20110238A (es) | Anticuerpos muc1* | |
| EA201490677A1 (ru) | Связывающие антиген cd27l белки | |
| DK201100184U1 (da) | Method for immunizing an avian species | |
| EP3331564A4 (en) | AGAINST MOLECULE TREATED ANTIGEN-BONDING CONSTRUCTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant of patent |